Moderna Inc (NAS:MRNA) Stock News, Headlines & Updates
Moderna Inc Stock News from GuruFocus
- 1
- 2
Jul 07, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Moderna, Inc. - MRNA
Marketwired • 10:00am
Jul 02, 2024
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
ACCESSWIRE • 11:06am
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PRNewswire • 10:00am
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
ACCESSWIRE • 7:00am
Jun 28, 2024
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna's RSV Vaccine, mRESVIA(R)
ACCESSWIRE • 7:00am
Jun 24, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PRNewswire • 6:00pm
Jun 15, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PRNewswire • 12:00pm
Jun 13, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
Marketwired • 3:00pm
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company's Next Generation COVID-19 Vaccine
ACCESSWIRE • 7:00am
Jun 10, 2024
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Business Wire • 10:00am
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
ACCESSWIRE • 7:00am
Jun 07, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PRNewswire • 3:00pm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PRNewswire • 3:00pm
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
ACCESSWIRE • 11:00am
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors Limiting Growth
GuruFocus Research • 10:01am
Jun 06, 2024
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program
ACCESSWIRE • 7:00am
Jun 05, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
Marketwired • 5:00pm
Jun 03, 2024
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Business Wire • 5:00pm
May 31, 2024
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
ACCESSWIRE • 3:00pm
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
ACCESSWIRE • 11:00am
May 28, 2024
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus Research • 9:32am
May 27, 2024
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barriers to Outperformance
GuruFocus Research • 10:01am
May 22, 2024
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
ACCESSWIRE • 7:00am
May 20, 2024
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barriers to Outperformance
GuruFocus Research • 10:01am
May 14, 2024
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors Limiting Growth
GuruFocus Research • 10:01am
May 13, 2024
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus Research • 9:31am
Moderna to Present at Upcoming Conferences in May/June 2024
ACCESSWIRE • 7:00am
May 10, 2024
Moderna Announces Update on Investigational RSV Vaccine
ACCESSWIRE • 7:00am
May 06, 2024
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barriers to Outperformance
GuruFocus Research • 10:01am
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus Research • 9:32am
May 04, 2024
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
GuruFocus Research • 11:01pm
May 03, 2024
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with Strategic Advances
GuruFocus Research • 1:04am
Q1 2024 Moderna Inc Earnings Call Transcript
GuruFocus Research • 11:13pm
May 02, 2024
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barriers to Outperformance
GuruFocus Research • 10:01am
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus Research • 5:52am
Apr 25, 2024
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
ACCESSWIRE • 7:00am
Apr 24, 2024
Moderna and OpenAI Collaborate To Advance mRNA Medicine
ACCESSWIRE • 11:00am
Apr 22, 2024
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign
ACCESSWIRE • 7:00am
Apr 17, 2024
Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
ACCESSWIRE • 7:00am
Apr 15, 2024
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barriers to Outperformance
GuruFocus Research • 10:01am
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news